Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 72.60M P/E - EPS this Y - Ern Qtrly Grth -
Income -17.55M Forward P/E -3.74 EPS next Y - 50D Avg Chg -21.00%
Sales 33.34M PEG - EPS past 5Y -24.05% 200D Avg Chg -22.00%
Dividend N/A Price/Book 3.83 EPS next 5Y - 52W High Chg -47.00%
Recommedations - Quick Ratio 2.82 Shares Outstanding 51.46M 52W Low Chg 46.00%
Insider Own 24.08% ROA -12.77% Shares Float 39.43M Beta 0.73
Inst Own 31.99% ROE -39.90% Shares Shorted/Prior 478.73K/507.80K Price 1.46
Gross Margin 43.66% Profit Margin 134.17% Avg. Volume 256,006 Target Price -
Oper. Margin -25.47% Earnings Date Nov 4 Volume 165,104 Change 0.00%
About Enzo Biochem, Inc.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

ENZ Chatroom

User Image PenkeTrading Posted - 2 days ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Enzo Biochem Inc. Is that bullish or bearish? $ENZ #RsiOversold #NYSE

User Image Chimeric Posted - 10/30/24

$ENZ Announced $0.10 dividend for holders as of Nov 15

User Image RallyRaider Posted - 1 month ago

$ENZ who knows the fundamentals? good bottom chart

User Image Uknowthe_thing Posted - 08/28/24

$ENZ Still listed ? Should be trading OTC .

User Image brenbto Posted - 3 months ago

$ENZ

User Image US_Patent_Plays Posted - 3 months ago

$ENZ Granted Broad US Patent #12061198 Today For "DIAGNOSIS AND TREATMENT OF VIRAL DISEASES (FOR PULMONARY FIBROSIS, LYMPHOMA, AND CANCER)". https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/12061198

User Image Trendybart Posted - 3 months ago

$ENZ Company fined 4.5 million for data breach by NY AG. Guess company feels investors don’t need to know. This the crap previous management pulled.

User Image NVDAMillionaire Posted - 07/30/24

$ENZ Enzo Biochem, Inc. (NYSE:ENZ): A Comprehensive Analysis of This Diversified Life Sciences Company http://beyondspx.com/2024/07/28/enzo-biochem-inc-nyseenz-a-comprehensive-analysis-of-this-diversified-life-sciences-company/

User Image NVDAMillionaire Posted - 4 months ago

$ENZ Enzo Biochem: Refocusing on Life Sciences Amid Challenges http://beyondspx.com/2024/07/12/enzo-biochem-refocusing-on-life-sciences-amid-challenges/

User Image Rxskillz Posted - 5 months ago

$ENZ looks good

User Image Chimeric Posted - 5 months ago

$ENZ This is valued at 57m which is equal to cash on hand. You get the growing business with improving margins for free. CEO comp was just changed to incentivize a sale over 1.50. I suspect this will fetch over $2…. Am I missing something?

User Image DonCorleone77 Posted - 5 months ago

$ENZ Enzo Biochem reports Q3 adjusted EPS (3c) vs. (7c) last year Reports Q3 revenue $8.02M vs. $7.49M last year. "The Company's transition to a focused manufacturer of a broad portfolio of Life Science tools, aligned in high-growth market segments with products used consistently by drug developers, is progressing favorably," said Kara Cannon, Enzo's Chief Executive Officer. "We continue to report significant revenue growth and the expansion of margins compared to the prior year, and the Company's significant debt and the associated covenants have been eliminated. Further, with the launch of the enhanced enzo.com, we are driving increased customer communication, interaction and market visibility. We hope that these financial and operational achievements will provide our shareholders with confidence in the Company's positive outlook."

User Image Stock_Titan Posted - 5 months ago

$ENZ Enzo Biochem Reports Third Quarter Fiscal 2024 Results and Provides Business Update https://www.stocktitan.net/news/ENZ/enzo-biochem-reports-third-quarter-fiscal-2024-results-and-provides-sna4wjylif9e.html

User Image NYC95Greg Posted - 5 months ago

$ENZ I love Enzo (ENZ) here. Business is great (all their end markets are growing rapidly). Margins rose nicely past 2 quarters. All they have to do is settle the first cyber lawsuit and then its clear sailing. -The 2nd lawsuit from the AG's should be immaterial: NY AG only fined Refuah Health $450,000 (“settled”) + $1.2m investment in preventative measures (Jan 2024). A small amount. According to the settlement agreement, Refuah neglected to change login credentials for 11 years, which allegedly exposed them to a cyberattack. As part of increased security measures, Refuah must appoint an employee to execute and sustain the chosen information security program. (Beckers Hospital review). -In 2021, Indiana AG sued Carepointe as 48,000 affected. A settlement has been reached that will see CarePointe pay $125,000 to resolve alleged violations of the (HIPAA) Act and state data privacy and security laws. Other than that, NO AG lawsuits for Ransomware attacks.

User Image Chimeric Posted - 05/28/24

$ENZ Anything brewing here? Or just a head fake? Hoping to get news on law suit settlement soon…

User Image John_Wick1234 Posted - 6 months ago

$ENZ Double Bottom.

User Image Gj64 Posted - 7 months ago

$ENZ https://fintel.io/so/us/enz

User Image Stock_Titan Posted - 8 months ago

$ENZ Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update https://www.stocktitan.net/news/ENZ/enzo-biochem-reports-second-quarter-fiscal-2024-results-and-provides-2c72bkqahkcn.html

User Image Captain516 Posted - 02/28/24

$ENZ this company is fucking doomed. They use and abuse their employees. Kara Shithead Cannon lines her pockets and treats her employees like shit. Ruined the life sciences division and then sold her employees off like cattle and then gave herself a raise and bonus. She can eat shit.

User Image NioUSD200 Posted - 02/26/24

$ENZ exited long ago. Just peeping to say hi to veterans

User Image TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for ENZ, Percentage Change of Average Monthly Price had More Negatives (68%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ENZ #ENZ #ENZStock #TickerDD #ENZPrice https://www.youtube.com/watch?v=nbq9Txb9bKY

User Image Chimeric Posted - 02/23/24

$ENZ . Drastically undervalued? Worth close to 3? Will higher prices ever be realized or is this a pipe dream? Long at 1.53 avg and been holding for several years.

User Image tickeron Posted - 01/23/24

If you’re trading this week, Read This! $ENZ price exceeded its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/4976792

User Image BaugHouldir Posted - 10 months ago

$ENZ can alone explain what is going on here?

User Image tickeron Posted - 10 months ago

A.I.dvisor made a bullish call on $ENZ, netting in a 15.38% gain over 2 weeks https://srnk.us/go/4963483

User Image tickeron Posted - 10 months ago

What do you think of this? $ENZ price may drop as it broke higher Bollinger Band. View odds of downtrend. https://srnk.us/go/4959199

User Image cctranscripts Posted - 10 months ago

Revised definitive proxy soliciting materials https://www.conferencecalltranscripts.org/summary/?id=12815197 $ENZ

User Image cctranscripts Posted - 10 months ago

Enzo Biochem just filed its Annual Report to Security Holders http://www.sec.gov/Archives/edgar/data/316253/000114036123058917/0001140361-23-058917-index.htm $ENZ

User Image risenhoover Posted - 10 months ago

$ENZ / Enzo Biochem files form ARS https://fintel.io/doc/null?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image Fullratio Posted - 11 months ago

$ENZ quick ratio has soared by 159% YoY and by 17% from the previous quarter: https://fullratio.com/stocks/nyse-enz/enzo-biochem

Analyst Ratings
Craig-Hallum Buy Feb 4, 14
Sidoti & Co. Neutral Jul 2, 13
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wolf James G. Other Other Feb 10 Buy 1.29 15,000 19,350 115,000 02/13/23
Wolf James G. 10% Owner 10% Owner Jan 27 Buy 1.4 11,800 16,520 4,090,000 01/30/23
Wolf James G. 10% Owner 10% Owner Oct 31 Buy 2.15 23,000 49,450 418,500 01/19/23
Wolf James G. 10% Owner 10% Owner Oct 31 Buy 2.15 23,000 49,450 418,500 01/18/23
Erfanian Hamid Chief Executive Offi.. Chief Executive Officer Nov 23 Buy 1.97 100,000 197,000 374,600 11/28/22
Cannon Kara Chief Operating Offi.. Chief Operating Officer Jul 15 Buy 2.42 2,500 6,050 2,500 07/19/22
Radoff Bradley Louis Director Director Jul 12 Buy 2.27 12,500 28,375 4,194,663 07/13/22
Radoff Bradley Louis Director Director Jul 05 Buy 2.20 120,000 264,000 4,182,163 07/06/22
Radoff Bradley Louis Director Director Jun 15 Buy 2.21 125,000 276,250 3,987,163 06/16/22